Health Canada Authorizes Generic Apo-Levothyroxine Tablets

Health Canada has issued a regulatory decision summary granting market authorization for Apo-Levothyroxine (100 mcg and 300 mcg levothyroxine sodium) tablets by Apotex Inc. This approval provides a generic formulation of levothyroxine tablets, indicated as replacement or supplemental therapy for patients with hypothyroidism.